Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $68.8200 (-1.11%) ($68.7800 - $71.1600) on Wed. Jul. 12, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.27% (three month average) | RSI | 13 | Latest Price | $68.8200(-1.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.7% a day on average for past five trading days. | Weekly Trend | LGND declines -3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) XBI(43%) IBB(42%) XHB(40%) XAR(38%) UNG(36%) | Factors Impacting LGND price | LGND will decline at least -1.135% in a week (0% probabilities). TBT(-25%) VXX(-20%) UUP(-19%) EDOC(-19%) XLU(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.135% (StdDev 2.27%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $62.9(-8.6%) | Resistance Level | $72.97 | 5 Day Moving Average | $69.54(-1.04%) | 10 Day Moving Average | $70.73(-2.7%) | 20 Day Moving Average | $72.97(-5.69%) | To recent high | -13.6% | To recent low | 0% | Market Cap | $1.106b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |